chrX-153786389-G-C

Variant summary

Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3

The NM_004135.4(IDH3G):​c.985C>G​(p.Leu329Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 25)

Consequence

IDH3G
NM_004135.4 missense

Scores

2
9
6

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.16
Variant links:
Genes affected
IDH3G (HGNC:5386): (isocitrate dehydrogenase (NAD(+)) 3 non-catalytic subunit gamma) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. NAD(+)-dependent isocitrate dehydrogenases catalyze the allosterically regulated rate-limiting step of the tricarboxylic acid cycle. Each isozyme is a heterotetramer that is composed of two alpha subunits, one beta subunit, and one gamma subunit. The protein encoded by this gene is the gamma subunit of one isozyme of NAD(+)-dependent isocitrate dehydrogenase. This gene is a candidate gene for periventricular heterotopia. Several alternatively spliced transcript variants of this gene have been described, but only some of their full length natures have been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.783

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
IDH3GNM_004135.4 linkuse as main transcriptc.985C>G p.Leu329Val missense_variant 11/13 ENST00000217901.10 NP_004126.1 P51553-1
IDH3GNM_174869.3 linkuse as main transcriptc.985C>G p.Leu329Val missense_variant 11/12 NP_777358.1 P51553-2O15384

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
IDH3GENST00000217901.10 linkuse as main transcriptc.985C>G p.Leu329Val missense_variant 11/131 NM_004135.4 ENSP00000217901.5 P51553-1

Frequencies

GnomAD3 genomes
Cov.:
25
GnomAD4 exome
Cov.:
31
GnomAD4 genome
Cov.:
25

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 02, 2024The c.985C>G (p.L329V) alteration is located in exon 11 (coding exon 11) of the IDH3G gene. This alteration results from a C to G substitution at nucleotide position 985, causing the leucine (L) at amino acid position 329 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Uncertain
0.046
T
BayesDel_noAF
Benign
-0.17
CADD
Benign
19
DANN
Uncertain
0.98
DEOGEN2
Uncertain
0.61
.;D;.;D;D
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Pathogenic
0.99
D;D;D;.;D
M_CAP
Uncertain
0.17
D
MetaRNN
Pathogenic
0.78
D;D;D;D;D
MetaSVM
Benign
-0.66
T
MutationAssessor
Benign
2.0
M;M;.;.;.
PrimateAI
Uncertain
0.63
T
PROVEAN
Benign
-1.8
N;N;N;N;.
REVEL
Uncertain
0.43
Sift
Uncertain
0.0070
D;D;D;D;.
Sift4G
Uncertain
0.034
D;D;D;D;D
Polyphen
1.0
.;D;.;.;.
Vest4
0.67
MutPred
0.62
Gain of catalytic residue at L329 (P = 0.03);Gain of catalytic residue at L329 (P = 0.03);Gain of catalytic residue at L329 (P = 0.03);.;.;
MVP
0.65
MPC
2.0
ClinPred
0.83
D
GERP RS
2.6
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.53
gMVP
0.93

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chrX-153051844; API